Mechanistically, miR-182 exerts this oncogenic role in CRC by targeting DAB2IP mRNA and activating the Wnt/β- catenin and PI3K/Akt/mTOR pathways [78]. The gene discussed is DAB2IP; the disease is colorectal carcinoma.